Anemia Clinical Trial
Official title:
The Efficacy of a Local Vitamin-C Rich Fruit (Guava) in Improving Iron Absorption From Mungbean Based Meals in Indian Children (6-10 Years)
Iron deficiency is estimated to affect about one fifth of the world's population, and women
and children are among the most severely affected. Evidence is mounting that iron deficiency
anemia adversely affects brain development with measurable effects on children's behavior,
motor development and cognition. In Hisar district of Haryana state, north- India, 58% of
school age children (6-10 years) are anemic, 49 % are iron deficient whereas 40 % have been
found to be anemic due to iron deficiency. Iron bioavailability calculated using algorithms
in regional diets ranged from 3.2 to 4.6 percent. Mungbean (Vigna radiata L.) is the third
most important legume crop of India. It is a high potential legume crop with 4-8 mg of iron
and known as a nutritious and healthy legume. Ascorbic acid is a potent enhancer of iron
absorption in humans which can counteract the inhibitory effect of phytic acid and
polyphenols. Guava is a popular and easily available fruit for this community having 200-
300 mg/100g of ascorbic acid. We will conduct a randomised controlled trial in school age
children (6-10 years) in Haryana state of India, to determine the efficacy of local
vitamin-C rich fruit guava with mungbean based meal on iron status of rural Indian children.
Objective: To assess the effect of mungbean based test meal on iron status (as body iron
stores, defined and calculated by the ratio of serum ferritin and serum transferrin
receptor) of school age children (6-10 years) with and without the consumption of guava, a
vitamin C rich fruit, in a school feeding program for seven months.
Study population: Three hundred school children aged between 6-10 years will be recruited
from two government school of Mangali village situated in Hisar district of Haryana state.
Study design: This intervention study will be carried out in a randomized controlled design.
Main study parameters/endpoints: Primary outcome will be the measurement of body iron stores
(mg/kg of body weight) based on the ratio of serum transferrin receptor to serum ferritin.
Primary Objective To measure the effect of mungbean based test meal on iron status (defined
by body iron stores, calculated as the ratio of ferritin and serum transferrin receptor) of
school age children (6-10 years) with and without the consumption of guava, a vitamin C rich
fruit, distributing in school feeding program for seven months.
Three weeks before the trial available children (6-10 years) in selected schools will be
screened for eligibility of the study on the basis of medical health questionnaire.
Deworming will be done at least 20 days before the start the feeding trial with a single
dose of Albendazole (400 mg), that will be given again after three months. These 300
children will be assigned to three groups (100 children each group). Group-1 will be served
with the normal school feeding program (SFP) meal (see annexure-1) and this group will also
serve as control group for the study. Group-2 will be served with mungbean test meal (see
annexure-2) and group-3 will be served with guava fruit in addition of mungbean test meal.
Meals to all children will be provided for six days in a week up to seven months. All meals
will be served at mid morning (11.00 am to 11.30 am). Effect of intervention will be
assessed in terms of iron status of children.
This study will be carried out in two government schools of Mangali village belong to
Hisar-1 block of Hisar district Haryana state with the close supervision of Chaudhary Charan
Singh Haryana Agriculture University, Hisar.
Children having severe anemia (Hb <7.0 g/dl) will be excluded from the trial and referred
for medical treatment.
Subjects will be recruited that comply with the following criteria:
- School children (6-10) years of age,
- enrolled in selected primary schools,
- Informed consent obtained from at least one parent or guardian,
- Children should be apparently healthy; i.e. have no pre-existing medical conditions or
be receiving chronic medication,
- Should not be allergic / hypersensitive to any of the ingredients of the test meal,
Should not consume mineral/vitamin supplements.
- If the child consume supplements he/she will be asked to stop taking the supplements
two weeks before the study and during the study.
A total of two blood samples will be taken from the participants, one at the start of the
study, and second at the end of the study. With each sampling 7ml blood will be taken by an
experienced technician. Blood will always be drawn in the morning between 7.30 and 9.00am at
particular school by the well trained technician. Hemoglobin in whole blood, serum ferritin
(Sf), serum transferrin receptor (sTfR), serum CRP and AGP will be analysed to compare the
iron status. Body iron stores will be calculated with the formula by Cook et. al. All
analysis will be carried out at the same time for both samples of baseline and after
intervention at St. John hospital, Bangalore. Therefore serum samples of baseline will be
stored for seven months at - 800c temperature. The CV of intra-assays and inter-assays will
be, monitored. Blood samples will not be destroyed after completion the study they will be
kept for up to 5 years.
Iron status will be compared in children belonging to three different groups in pre and post
conditions, using above mentioned iron status indicators. Height and weight of the children
will also be measured at pre and post of the intervention study. The primary outcome of this
study will be body iron stores calculated with the cook formula.
Secondary outcomes will be prevalence of iron deficiency, anaemia, and difference in
haemoglobin concentration and plasma concentrations of ferritin, and soluble transferring
receptor in the two treatment groups. Anemia will be defined as a hemoglobin concentration
<11.5g/L and iron deficiency will be defined as an SF concentration <12µg/l. The cut-off for
normal CRP and AGP are defined at <5mg/L and <1g/L(12), respectively. Anthropometric indices
will be calculated using WHO (2006) (10) Child growth standards. Being stunted, underweight
or wasted will be defined by Z score <-2SD for height-for-age, weight-for-age and
weight-for-height respectively.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Prevention
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT00801931 -
Double Cord Blood Transplant for Patients With Malignant and Non-malignant Disorders
|
Phase 1/Phase 2 | |
Completed |
NCT02948283 -
Metformin Hydrochloride and Ritonavir in Treating Patients With Relapsed or Refractory Multiple Myeloma or Chronic Lymphocytic Leukemia
|
Phase 1 | |
Completed |
NCT03341338 -
Genes-in-Action - Hepcidin Regulation of Iron Supplementation
|
||
Completed |
NCT00060398 -
Epoetin Alfa With or Without Dexamethasone in Treating Fatigue and Anemia in Patients With Hormone-Refractory Prostate Cancer
|
Phase 3 | |
Recruiting |
NCT05384691 -
Efficacy of Luspatercept in ESA-naive LR-MDS Patients With or Without Ring Sideroblasts Who do Not Require Transfusions
|
Phase 2 | |
Not yet recruiting |
NCT06309641 -
Methemoglobinemia Following Intravenous Iron Treatment
|
||
Completed |
NCT02912494 -
A Phase III Study of JR-131 in Renal Anemia Patients With Chronic Kidney Disease (CKD)
|
Phase 3 | |
Completed |
NCT02912533 -
A Long-term Study of JR-131 in Renal Anemia Patients With Chronic Kidney Disease (CKD)
|
Phase 3 | |
Completed |
NCT03822884 -
Pharmacokinetic/Pharmacodynamic Study of 3 Subcutaneous Single Dose Epoetin Alfa Formulations in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT02888171 -
Impact of Ferric Citrate vs Ferrous Sulfate on Iron Parameters and Hemoglobin in Individuals With CKD and Iron Deficiency
|
N/A | |
Completed |
NCT02930850 -
Spot-Check Noninvasive Hemoglobin (SpHb) Clinical Validation
|
N/A | |
Completed |
NCT02603250 -
Evaluation of Hemoglobin Measurement Tools for Child Anemia Screening in Rwanda
|
N/A | |
Completed |
NCT02384122 -
Efficacy of Octreotide on Blood and Iron Requirements in Patients With Anemia Due to Angiodysplasias
|
Phase 3 | |
Completed |
NCT02176759 -
Iron Absorption From Rice Fortified With Ferric Pyrophosphate
|
N/A | |
Completed |
NCT01922479 -
Pilot Study of Ferric Carboxymaltose to Treat Iron Deficiency in Asians With Heart Failure
|
Phase 4 | |
Completed |
NCT02310113 -
Transfusion and Skeletal Muscle Tissue Oxygenation
|
N/A | |
Withdrawn |
NCT01934842 -
A Study to Compare Analyte Levels in Blood Collected Using an Investigational Collection Device With a Commercial Predicate
|
N/A | |
Completed |
NCT01693029 -
Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa
|
Phase 3 | |
Terminated |
NCT01535781 -
Study of the Effect of Tranexamic Acid Administered to Patients With Hip Fractures. Can Blood Loss be Reduced?
|
N/A | |
Completed |
NCT01432717 -
Study of ACE-536 in Healthy Postmenopausal Women
|
Phase 1 |